Abstract
Purpose
The authors investigated whether contrast-enhanced cardiovascular magnetic resonance (CMR) imaging may be used to detect early cardiac involvement in patients with systemic sclerosis (SSc).
Materials and methods
Twenty-six SSc patients (nine with diffuse cutaneous SSc and 17 with limited cutaneous SSc) and 13 sex- and age-matched healthy controls (HC) were studied. Contrast-enhanced CMR allowed the analysis of first-pass images (areas of hypo-enhancement indicating perfusion defects) and delayed images (persistent hyper-enhancement indicating fibrosis). Clinical variables including disease duration and presence of major visceral complications of SSc were investigated in each patient.
Results
Perfusion defects were detected in 53.8 % of SSc patients but in none of the HC. Perfusion abnormalities were detected in 28.6 % of SSc patients with disease duration less than 2 years and in 29.2 % of asymptomatic SSc patients. Delayed contrast enhancement was present in 25 % of SSc patients but not in HC. All patients with delayed contrast enhancement showed first-pass hypoperfusion. Right ventricular wall thickness was significantly increased in all SSc patients when compared to HC (p < 0.001); a similar trend was observed when SSc patients without pulmonary arterial hypertension were analysed (p < 0.04). A trend to lower end-diastolic and end-systolic right ventricular volumes in SSc versus HC was observed (p < 0.05 and p < 0.04, respectively).
Conclusions
Myocardial hypoperfusion is common in SSc and occurs early in the course of the disease. Co-localisation of perfusion defects and delayed contrast enhancement indicative of fibrosis suggests that myocardial hypoxia may play a role in the pathogenesis of myocardial fibrosis.
Similar content being viewed by others
References
Black CM, Denton CP (1998) Systemic sclerosis and related disorders in adults and children. In: Maddison PG, Isenberg DA, Woo P, Glass DN (eds) Oxford Textbook of Rheumatology, Oxford University Press, Inc. 2nd edn. vol 2, pp 1217–1247
Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841–860
Coghlan JG, Mukerjee D (2001) The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol 13:495–499
Steen V (2004) The heart in systemic sclerosis. Curr Rheumatol Rep 6:137–140
Medsger TA Jr, Masi AT (1973) Survival with scleroderma-II. A life-table analysis of clinical and demographic factors in 358 male US veteran patients. J Chron Dis 26:647–660
Follansbee WP, Miller TR, Curtiss EL et al (1990) A controlled clinico-pathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 17:656–662
Marzullo P, Parodi O, Sambuceti G et al (1995) Myocardial viability: nuclear medicine versus stress echocardiography. Echocardiography 12:291–302
Valentini G, Vitale DF, Giunta A et al (1996) Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 55:455–460
Armstrong GP, Whalley GA, Doughty RN et al (1996) Left ventricular function in scleroderma. Br J Rheumatol 35:983–988
Ferri C, Di Bello V, Martini A et al (1998) Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study. Ann Rheum Dis 57:296–302
Pennell D (2001) Imaging techniques. Cardiovascular magnetic resonance. Heart 85:581–589
Panting JR, Gatehouse PD, Yang GZ et al (2002) Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346:1948–1953
Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age and contractile function. Circulation 100:1992–2002
Karwatowski S, Chronos A, Sinclaire H et al (2000) Effect of systemic sclerosis on left ventricular long-axis motion and left ventricular mass assessed by magnetic resonance. J Cardiovasc Magn Reson 2:109–117
Moon J, Coghlan JG, Pennell DJ (2001) Systemic sclerosis involving the heart. Heart 86:308
Dziadzio M, Giovagnoni A, Pomponio G et al (2003) Acute myocarditis associated with adenoviral infection in a patient with scleroderma. Clin Rheumatol 22:487–490
Plastiras SC, Kelekis N, Tzelepis GE (2006) Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 354:2194–2196
Tzelepis GE, Kelekis NL, Plastiras SC et al (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56:3827–3836
Hachulla AL, Launay D, Gaxotte V et al (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68:1878–1884
Kobayashi H, Yokoe I, Hirano M et al (2009) Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 36:106–112
Mavrogeni S, Bratis K, van Wijk K et al (2012) Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. Int J Cardiol 159:e56–e58
Subcommitee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
LeRoy EC, Black CM, Fleishmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin N Am 29:255–273
Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S (2003) Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 21(Suppl. 29):S47–S56
Appendix. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc. Clin Exp Rheumatol 2003;21(Suppl.29):S49–S56
Ferri C, Emdin M, Nielsen H, Bruhlmann P (2003) Assessment of heart involvement. Clin Exp Rheumatol 21(Suppl. 29):S24–S28
Committee Guidelines (2003) European Society of hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011–1053
Sahn DJ, De Maria A, Kissi S, Wayman A (1978) Recommendations regarding quantification in M-mode echocardiography: results of a series of echocardiographic measurements. Circulation 58:1072–1083
Barst RJ, McGoon M, Torbicki A et al (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. JACC 43(Suppl S):40S–47S
Lin CC, Ding HJ, Chen YW et al (2003) Usefulness of technetium-99m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis. Int J Cardiol 92:157–161
Nakajima K, Kawano M, Hasegawa M et al (2006) Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging. Circ J 70:1481–1487
Sulli A, Ghio M, Bezante GP et al (2004) Blunted coronary flow reserve in systemic sclerosis. Rheumatology 43:505–509
D’Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428–440
Akram MR, Handler CE, Williams M et al (2006) Angiographically proven coronary artery disease in scleroderma. Rheumatology 45:1395–1398
Avouac J, Fransen J, Walker UA et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70:476–481
Di Cesare E, Battisti S, Di Sibio A et al (2013) Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol 82:e268–e273
Acknowledgments
This study was supported by grants from Fondazione Italiana Ricerca Artrite (FIRA) and Ministero Italiano per l’Università e la Ricerca Scientifica (MIUR) to A.G., and from Fondazione di Medicina Molecolare e Terapia Cellulare, Università Politecnica delle Marche, Ancona, Italy.
Conflict of interest
N. Schicchi, G. Valeri, G. Moroncini, G. Agliata, L. Salvolini, A. Gabrielli and A. Giovagnoni declare that they have no conflict of interest.
Ethical statement
The research was carried out in compliance with the Helsinky Declaration. The study was approved by the Institutional Ethics Committee of Azienda Ospedali Riuniti, Università Politecnica delle Marche, Ancona, Italy, and informed consent was obtained from all subjects participating in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schicchi, N., Valeri, G., Moroncini, G. et al. Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Radiol med 119, 885–894 (2014). https://doi.org/10.1007/s11547-014-0419-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-014-0419-7